Clinical and Virological Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern: A Retrospective Cohort Study Comparing B.1.1.7 (Alpha), B.1.351 (Beta), and B.1.617.2 (Delta)중증 급성 호흡기 증후군 코로나바이러스 2(SARS-CoV-2) 우려 변이의 임상 및 바이러스학적 특징: B.1.1.7(알파), B.1.351(베타) 및 B.1.617.2(베타)를 비교한 후향적 코호트 연구( 델타)Article Published on 2022-08-242022-09-11 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 변종, [키워드] 95% confidence interval adjusted odds ratio Admission age age and sex analyzed B.1.1.7 B.1.351 B.1.617.2 Beta Chain Reaction clinical clinical outcomes Cohort Comorbidities coronavirus 2 COVID-19 Ct value Ct values cycle threshold death Delta disease severity higher odd higher odds implementation Infection intensive care intensive care unit admission median not seen outcome oxygen Oxygen requirement Patient patients Pneumonia polymerase chain polymerase chain reaction respiratory Retrospective study SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants severity severity of illness Sex significantly lower Singapore study period surveillance data vaccination Vaccination Status variants variants of concern variants of concern. viral shedding VoC VOCs were infected wild-type wild-type strain [DOI] 10.1093/cid/ciab721 PMC 바로가기 [Article Type] Article
Clinical manifestations and disease severity of SARS-CoV-2 infection among infants in Canada캐나다 영유아에서 SARS-CoV-2 감염의 임상 증상 및 질병 중증도Article Published on 2022-08-242022-09-11 Journal: PLoS ONE [Category] SARS, 치료기술, [키워드] absence acute COVID-19 age approved Asymptomatic Canada Care Characteristics Clinical management clinical manifestation clinical manifestations clinics Cohort comorbid condition comorbid conditions condition coryza cough COVID-19 criteria defined disease severity Fever help higher odd higher odds Hospitalization Hospitalized identify incidentally detected Infant Infants Infrastructure initial Inpatient Logistic regression main analysis microbiologically Mild moderate moderate or severe disease multivariable logistic regression National oral intake outcome Outpatient outpatients patient with SARS-CoV-2 presenting symptom Program Prospective Study Public health interventions reported SARS-CoV-2 SARS-COV-2 infection severe COVID-19 severe disease severity strain Vaccine was performed [DOI] 10.1371/journal.pone.0272648 PMC 바로가기 [Article Type] Article
SARS-CoV-2 RT-PCR positivity in relation to clinical and demographic characteristics in residents of border quarantine centres, Khyber Pakhtunkhwa, Pakistan: a prospective cohort study파키스탄 Khyber Pakhtunkhwa 국경 검역소 거주자의 임상 및 인구 통계학적 특성과 관련된 SARS-CoV-2 RT-PCR 양성: 전향적 코호트 연구Article Published on 2022-08-052022-09-11 Journal: Transactions of the Royal Society of Tropical Medi [Category] SARS, 변종, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 adjusted odds ratio adjusted odds ratios age Analysis association Asymptomatic asymptomatic infection calculate calculated Chain Reaction conducted coronavirus COVID-19 demographic characteristics driver effective groups hazard ratio hazard ratios healthy higher odd higher odds individual individuals Infection International Isolation Kaplan-Meier Kaplan-Meier curve Kaplan-Meier curves less Logistic regression Mantel-Haenszel Measures Older age Pakistan Period period prevalence polymerase chain polymerase chain reaction positive pre-symptomatic Prevalence primary source prospective cohort study quarantine remained reverse transcription SARS-CoV-2 SARS-CoV-2 RT-PCR Sex significantly tested Time-to-event Transmission Transmission. TTE variants was used were assessed [DOI] 10.1093/trstmh/trac057 PMC 바로가기 [Article Type] Article
Increased risk of severe COVID-19 in hospitalized patients with SARS-CoV-2 Alpha variant infection: a multicentre matched cohort studySARS-CoV-2 알파 변종 감염으로 입원한 환자에서 심각한 COVID-19 위험 증가: 다기관 일치 코호트 연구Multicenter Study Published on 2022-06-132022-09-11 Journal: BMC Infectious Diseases [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI Admission age Alpha variant Analysis both groups cohort study Comorbidities Comorbidity conducted COVID-19 Data collection defined Factor France higher odd higher odds Hospitalization Hospitalized hospitalized patient hospitals in both group Increased lineages logistic regression model male median age multicentre non-rebreather mask participant Patient patients hospitalized primary endpoint proportion retrospective risk SARS-CoV-2 severe COVID-19 severity severity of COVID-19 Sex stratified the disease variant Variant of concern Alpha. VoC [DOI] 10.1186/s12879-022-07508-x PMC 바로가기 [Article Type] Multicenter Study
Rapid emergence of SARS-CoV-2 Omicron variant is associated with an infection advantage over Delta in vaccinated personsSARS-CoV-2 Omicron 변이의 급속한 출현은 예방 접종을 받은 사람에서 Delta보다 감염 이점과 관련이 있습니다.Article Published on 2022-05-132022-09-11 Journal: Med (New York, N.Y.) [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] analyzed CDC center collected Connecticut Control COVID-19 COVID-19 vaccines Delta delta variant determine disease control displacement dominant dose doses doubling driven by Epidemiology Factor Generalized genomic Genomic surveillance genomic surveillance. higher odd higher odds Infection infections Linear model nasal swab odds of infection omicron Omicron variants PCR test positive prevention proportion Rapid reduction in SARS-CoV-2 spike gene Spread supported Surveillance vaccination Vaccination Status Vaccine vaccine dose vaccine doses Vaccine-induced immunity variant virus were infected were used [DOI] 10.1016/j.medj.2022.03.010 PMC 바로가기 [Article Type] Article
Changes in medical and non-medical cannabis use among United States adults before and during the COVID-19 pandemicCovid-19 Pandemic 전과 기간 동안 미국 성인의 의료 및 비 의료 대마초 사용의 변화Article Published on 2022-05-042022-08-31 Journal: The American journal of drug and alcohol abuse [Category] COVID19(2023년), MERS, SARS, 치료제, [키워드] adjusted AOR association cannabinoids cannabinoids. cannabis change changes in consequence COVID-19 COVID-19 pandemic Frequency Health higher odd higher odds implication increases in Logistic regression media notable pandemic participant Population recruited reported SARS-CoV-2 SARS-CoV-2 pandemic social media the SARS-CoV-2 the United State thought United State United States [DOI] 10.1080/00952990.2021.2007257 PMC 바로가기 [Article Type] Article
Rates of Severe Outcomes After Bamlanivimab-Etesevimab and Casirivimab-Imdevimab Treatment of High-Risk Patients With Mild to Moderate Coronavirus Disease 20192019년 경증에서 중등도의 코로나바이러스 질환이 있는 고위험 환자의 밤라니비맙-에테세비맙 및 카시리비맙-임데비맙 치료 후 심각한 결과의 비율Article Published on 2022-05-012022-09-11 Journal: Mayo Clinic proceedings [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] 95% CI acute respiratory syndrome acute respiratory syndrome coronavirus Alpha bamlanivimab Casirivimab Clinical characteristics Clinical efficacy Clinical outcome clinical outcomes clinical study Cohort cohorts of patient coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 demographic and clinical characteristics drug Efficacy emergency treatment etesevimab food higher odd higher odds Hospitalization Imdevimab Mild mild to moderate Mild to moderate COVID-19 moderate Moderate COVID-19 monoclonal antibodies monoclonal antibody not significantly different observation Odds ratio outcome oxygen oxygen supplementation Patient progression Rate reason respiratory Retrospective study severe acute respiratory syndrome Coronavirus significant difference significantly higher treated Treatment US Food and Drug Administration variants wild-type [DOI] 10.1016/j.mayocp.2022.02.009 PMC 바로가기 [Article Type] Article
Effectiveness of Monoclonal Antibodies in Preventing Severe COVID-19 With Emergence of the Delta Variant델타 변이체의 출현으로 심각한 COVID-19를 예방하는 모노클로날 항체의 효과Article Published on 2022-02-012022-09-11 Journal: Mayo Clinic proceedings [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] 95% CI adjusted Alpha Anti-spike anti-spike monoclonal antibodies anti-spike monoclonal antibody approved Beta Beta variant beta variants can not Charlson Comorbidity Index clinical setting Cohort Comorbidity COVID-19 death Delta delta variant effective strategy Effectiveness Efficacy emergence epoch excluded higher odd higher odds Hospitalization infused maintain monoclonal monoclonal antibodies monoclonal antibody Odds ratio outcome Patient predominant Preventing question retrospective cohort severe disease Severe infection the SARS-CoV-2 Treatment variant virulent [DOI] 10.1016/j.mayocp.2021.12.002 PMC 바로가기 [Article Type] Article
Seroprevalence of anti-SARS-CoV-2 antibodies among staff at primary healthcare institutions in PrishtinaPrishtina의 1 차 의료 기관 직원들 사이에서 항 -SARS-COV-2 항체의 혈청 유병률Research Published on 2022-01-162022-09-01 Journal: BMC Infectious Diseases [Category] SARS, 진단, [키워드] 95% CI addressed adjusted affected anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody antibody assist association calculated capital city carried Contact COVID-19 cross-sectional survey Epidemiology examined Factor Factors family members Gender healthcare healthcare facility healthcare worker Healthcare workers herd immunity high-risk population higher education higher odd higher odds IgG IgM Immunity Infectious diseases Kosovo maintain male measure Other outcomes over Patient PCR PCR test Physicians Population positive positive PCR test Positive test Prevalence Protective public health questionnaire Questionnaires Result SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody Serological testing serology seropositive Seropositivity Seroprevalence significantly increased Spread tested vaccination [DOI] 10.1186/s12879-022-07038-6 PMC 바로가기 [Article Type] Research
Coinfection between SARS-CoV-2 and vector-borne diseases in Luanda, Angola앙골라 루안다에서 SARS-CoV-2와 매개체 매개 질병 간의 동시 감염Article Published on 2022-01-012022-09-11 Journal: Journal of medical virology [Category] SARS, 진단, 치료기술, [키워드] Algorithm Angola capital city Co-infection co-occurrence Coinfection conducted COVID-19 cross-sectional cross-sectional study Dengue Diagnosis Epidemics generate Healthcare systems higher odd higher odds highlight Infection Luanda malaria male measure Odds ratio participant positive promote SARS-CoV-2 subject tested the SARS-CoV-2 treatment protocols Vector-borne disease vector-borne diseases vector-borne diseases. [DOI] 10.1002/jmv.27354 PMC 바로가기 [Article Type] Article